Home » Stocks » CMLT » Company

CM Life Sciences III, Inc. (CMLT)

CM Life Sciences III currently trades with the ticker symbol CMLTU
Stock Price: $11.20 USD -0.05 (-0.44%)
Updated Apr 9, 2021 4:00 PM EDT - Market closed
After-hours: $11.15 -0.05 (-0.45%) Apr 9, 4:02 PM
CM Life Sciences III, Inc.
Founded 2021
IPO Date Apr 7, 2021

Stock Information

Ticker Symbol CMLT
Exchange NASDAQ
Reporting Currency US Dollars
IPO Price $10.00
CIK Code 1843762
Employer ID 86-1691173

Company Description

CM Life Sciences III is a newly organized blank check company incorporated for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses.

While we may pursue an initial business combination target in any industry, sector or geographic region, we intend to capitalize on our management team’s background and experience to identify promising opportunities in the life sciences sector.

Eli Casdin, our Chief Executive Officer, founded Casdin Capital, LLC, an investment firm focused on the life sciences and healthcare industry, in November 2011 and currently serves as its Chief Investment Officer.

Casdin Capital’s investment strategy includes but also extends beyond traditional drug development, finding opportunity in the vast universe of companies at the epicenter of innovation, spanning biotechnology and its many constituents.

Companies beyond drug developers include developers of molecular-based diagnostics, providers of tools, developers of technology and data assets and operators of service companies that support research, development and product commercialization.

Key Executives

NamePosition
Eli D. CasdinChief Executive Officer and Director
Keith A. MeisterChairman
Brian EmesChief Financial Officer and Secretary
Shaun RodriguezChief Strategy Officer